Robert Kramer
2018 - Emergent BioSolutions
Compensation breakdown
Non-Equity Incentive Plan | $538,807 |
---|---|
Option Awards | $649,980 |
Salary | $549,047 |
Stock Awards | $649,930 |
Other | $8,983 |
Total | $2,396,747 |
Kramer received $650K in option awards, accounting for 27% of the total pay in 2018.
Kramer also received $538.8K in non-equity incentive plan, $549K in salary, $649.9K in stock awards and $9K in other compensation.
Rankings
In 2018, Robert Kramer's compensation ranked 4,855th out of 14,244 executives tracked by ExecPay. In other words, Kramer earned more than 65.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,855 | 66th |
Manufacturing | 1,822 | 68th |
Chemicals And Allied Products | 663 | 69th |
Drugs | 557 | 69th |
Pharmaceutical Preparations | 431 | 69th |
Kramer's colleagues
We found six more compensation records of executives who worked with Robert Kramer at Emergent BioSolutions in 2018.
2018
Daniel Abdun-Nabi
Emergent BioSolutions
Chief Executive Officer
2018
Fuad El-Hibri
Emergent BioSolutions
Chairman
2018
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
2018
Atul Saran
Emergent BioSolutions
General Counsel
2018
Adam Havey
Emergent BioSolutions
Executive Vice President, Business Operations
2018
Richard Lindahl
Emergent BioSolutions
Chief Financial Officer
News
April 15, 2022
April 9, 2021
April 28, 2020
April 9, 2020
April 26, 2019